FOXA vs PCSA · P/E 14, rev $17.13B vs $5.9M cap
Fox Corp Class A (FOXA) versus Processa Pharmaceuticals Inc (PCSA) — a side-by-side from cached financials, not a winner call.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported FOXA revenue for 2026-06-30 was $17.13B. Net income was $1.73B. Revenue was up 5.1% from 2025-06-30 to 2026-06-30. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Latest reported PCSA revenue for 2023-09-30 was $0. Net income was -$2.1M. PCSA currently screens at market cap $5.9M.
FOXA currently screens at market cap $24.50B and trailing P/E 14.1. PCSA currently screens at market cap $5.9M.
Not investment advice. Open the FOXA and PCSA stock pages for the full models.
Not investment advice.